322 related articles for article (PubMed ID: 33385879)
1. Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (COVID-19) as well as other virus-induced "cytokines storm".
Giuliani C; Bucci I; Napolitano G
Med Hypotheses; 2021 Jan; 146():110473. PubMed ID: 33385879
[TBL] [Abstract][Full Text] [Related]
2. Phenylmethimazole inhibits production of proinflammatory mediators and is protective in an experimental model of endotoxic shock*.
Benavides U; Gonzalez-Murguiondo M; Harii N; Lewis CJ; Schwartz AL; Giuliani C; Napolitano G; Dagia NM; Malgor R; McCall KD; Kohn LD
Crit Care Med; 2012 Mar; 40(3):886-94. PubMed ID: 22020240
[TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis and treatment of cytokine storm in COVID-19.
Kim JS; Lee JY; Yang JW; Lee KH; Effenberger M; Szpirt W; Kronbichler A; Shin JI
Theranostics; 2021; 11(1):316-329. PubMed ID: 33391477
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.
Pum A; Ennemoser M; Adage T; Kungl AJ
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33445810
[TBL] [Abstract][Full Text] [Related]
5. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
6. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.
Shawki MA; Elsayed NS; Mantawy EM; Said RS
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):395-409. PubMed ID: 34057871
[TBL] [Abstract][Full Text] [Related]
7. AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm.
Gangemi S; Tonacci A
Cytokine Growth Factor Rev; 2021 Apr; 58():111-113. PubMed ID: 32938545
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells.
Hafezi B; Chan L; Knapp JP; Karimi N; Alizadeh K; Mehrani Y; Bridle BW; Karimi K
Cells; 2021 Jul; 10(7):. PubMed ID: 34359931
[TBL] [Abstract][Full Text] [Related]
9. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.
Rossi M; Piagnerelli M; Van Meerhaeghe A; Zouaoui Boudjeltia K
Med Hypotheses; 2020 Nov; 144():110242. PubMed ID: 33254548
[TBL] [Abstract][Full Text] [Related]
10. The role of HMGB1 in COVID-19-induced cytokine storm and its potential therapeutic targets: A review.
Wulandari S; Hartono ; Wibawa T
Immunology; 2023 Jun; 169(2):117-131. PubMed ID: 36571562
[TBL] [Abstract][Full Text] [Related]
11. Cytokines and COVID-19: friends or foes?
Rokni M; Hamblin MR; Rezaei N
Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579
[TBL] [Abstract][Full Text] [Related]
12. Cytokine Drizzle-The Rationale for Abandoning "Cytokine Storm".
Stolarski AE; Kim J; Zhang Q; Remick DG
Shock; 2021 Nov; 56(5):667-672. PubMed ID: 34652339
[TBL] [Abstract][Full Text] [Related]
13. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
14. A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.
Rehan M; Ahmed F; Howladar SM; Refai MY; Baeissa HM; Zughaibi TA; Kedwa KM; Jamal MS
Front Immunol; 2021; 12():648250. PubMed ID: 34248936
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
16. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
[TBL] [Abstract][Full Text] [Related]
17. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
[TBL] [Abstract][Full Text] [Related]
18. Phenylmethimazole suppresses dsRNA-induced cytotoxicity and inflammatory cytokines in murine pancreatic beta cells and blocks viral acceleration of type 1 diabetes in NOD mice.
McCall KD; Schmerr MJ; Thuma JR; James CB; Courreges MC; Benencia F; Malgor R; Schwartz FL
Molecules; 2013 Mar; 18(4):3841-58. PubMed ID: 23535518
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of LPS-induced TLR4 signaling products in murine macrophages by phenylmethimazole: an assay methodology for screening potential phenylmethimazole analogs.
Deosarkar SP; Bhatt P; Gillespie J; Goetz DJ; McCall KD
Drug Dev Res; 2014 Dec; 75(8):497-509. PubMed ID: 25408546
[TBL] [Abstract][Full Text] [Related]
20. Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19.
Manayi A; Nabavi SM; Khayatkashani M; Habtemariam S; Khayat Kashani HR
Mol Biol Rep; 2021 Dec; 48(12):8221-8225. PubMed ID: 34655016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
